ArticlePharmacogenomics2013

CYP2D6 genotype predicts tamoxifen side effects but not cancer-free or survival benefits in postmenopausal ER+ and/or PgR+ breast cancers.

Jennifer Catalano et al.PubMed ↗

No numbers read from the abstract.